This website uses cookies to enhance the user experience.
21st logo
||
ER

Elind Rebekka1989

Shareholdings
21
Arrow
2
Double arrow
Norway Business roles
0

Roles

No available data

Related industries

No related industries

Direct relationships

No direct relationships

Shares owned by Elind Rebekka

NameShare classTotal operating incomeTotal equityShare
Ordinære aksjer
0
-34,331
50 %
directly
R
RANTEN AS
B-aksjer
0
2,385,590
20 %
directly
K
KRBV 37 AS
1,183,273
30,000
20 %
indirectly
S
SJØGATA 2 AS
616,195
-428,146
4.75 %
indirectly
C
COMMFIDES NORGE AS
Ordinære aksjer
15,259,208
2,013,932
0.16 %
directly < 0.01 %
E
ENSURGE MICROPOWER ASA
Ordinære aksjer
0
59,115,000
< 0.01 %
directly
H
HYDROGENPRO ASA
Ordinære aksjer
95,213,000
397,248,000
< 0.01 %
directly
O
ORKLA ASA
Ordinære aksjer
292,000,000
67,318,000,000
< 0.01 %
directly
V
VISTIN PHARMA ASA
Ordinære aksjer
0
139,593,000
< 0.01 %
directly
E
EQUINOR ASA
Ordinære aksjer
67,956,000,000
39,182,000,000
< 0.01 %
directly
D
DOF GROUP ASA
Ordinære aksjer
0
2,088,000,000
< 0.01 %
directly
K
KONGSBERG AUTOMOTIVE ASA
Ordinære aksjer
8,900,000
267,700,000
< 0.01 %
directly
N
NORDIC SEMICONDUCTOR ASA
Ordinære aksjer
477,595,000
515,052,000
< 0.01 %
directly
R
REC SILICON HOLDINGS AS
Ordinære aksjer
0
16,124,000
< 0.01 %
directly
M
MAGNORA ASA
Ordinære aksjer
134,000,000
0
< 0.01 %
directly
P
POLIGHT ASA
Ordinære aksjer
9,624,000
227,558,000
< 0.01 %
directly
E
ELLIPTIC LABORATORIES ASA
Ordinære aksjer
102,736,000
179,826,000
< 0.01 %
directly
N
NORDIC MINING ASA
Ordinære aksjer
9,336,000
2,050,397,000
< 0.01 %
directly
A
AKER BP ASA
Ordinære aksjer
10,943,000,000
11,226,000,000
< 0.01 %
directly
N
NYKODE THERAPEUTICS ASA
Ordinære aksjer
453,000
94,977,000
< 0.01 %
directly
P
PCI BIOTECH HOLDING ASA
Under liquidation
Ordinære aksjer
0
0
< 0.01 %
directly
S
SAGA PURE ASA
Ordinære aksjer
14,120,000
1,121,963,000
< 0.01 %
directly
M
MORROW BANK ASA
Closed
Ordinære aksjer
-
-
< 0.01 %
directly

Limited to direct ownership positions of 0.5% or more.

Last update: Sep 25, 2026